Home » Topics » BioWorld Science

BioWorld Science
RSS

Anti-IL-23 therapy with mirikizumab shows activity in ulcerative colitis trial

June 6, 2018

Researchers present first-in-human data for Bayer's BAY-1251152 in advanced cancers

June 5, 2018

CytRx launches new subsidiary Centurion Biopharma

June 5, 2018

Preclinical study shows Cynata's MSCs are effective in model of diabetic ulcers

June 5, 2018

FDA grants priority review to Hemlibra sBLA

June 5, 2018

Primary efficacy endpoint not achieved in phase II study of teslexivir gel in condyloma

June 5, 2018

Yakult licenses rights to duvelisib in Japan

June 5, 2018

Perjeta approved in E.U. for adjuvant treatment of HER2-positive early breast cancer

June 5, 2018

Mabion submits MAA for rituximab biosimilar Mabion-CD20

June 5, 2018

Isomer discovery could yield countless new drugs

June 5, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 29, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 26, 2026
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
Researchers identify innate immune barrier against melanoma
BioWorld
Australian researchers have identified a previously overlooked population of immune cells in the skin that physically restrain melanoma growth by engulfing live...
Cavalon Therapeutics and Northwestern patent new Cav1.3 blockers
BioWorld Science
Cavalon Therapeutics Inc. and Northwestern University have disclosed new voltage-gated calcium channel Cav1.3 blockers potentially useful for the treatment of...